Nancy C. Andrews, M.D., Ph.D., has served as Executive Vice President and Chief Scientific Officer at Boston Children's Hospital since December 2021 and as Professor in Residence at Harvard Medical School since November 2023. She previously served as Professor of Pediatrics and Professor of Pharmacology & Cancer Biology at Duke University from 2007 to December 2021, and from 2007 to 2017 was Dean of the Duke University School of Medicine and Vice Chancellor for Academic Affairs at Duke University. From 2003 to 2007 she served as Dean for Basic Sciences and Graduate Studies and Professor of Pediatrics at Harvard University Medical School, and from 1999 to 2003 was director of the Harvard-Massachusetts Institute of Technology M.D./Ph.D. Program and principal investigator of its MSTP grant. From 1993 to 2006 she was a biomedical research investigator of the Howard Hughes Medical Institute.
Dr. Andrews is an elected member of the American Academy of Arts and Sciences, the National Academy of Medicine and the National Academy of Sciences, where she currently serves as Home Secretary. She previously served as Chair of the Boards of Directors of the American Academy of Arts and Sciences and the Burroughs Wellcome Fund and is a former member of the Scientific Management Review Board at the National Institutes of Health. She serves on the boards of directors of Novartis International AG and Maze Therapeutics and on the MIT Corporation, and is a member of the Scientific Advisory Boards of Dyne Therapeutics and Cajal Therapeutics.
Dr. Andrews has been a director of Charles River since February 2020. She was selected for the Board in recognition of her perspective as an accomplished physician, scientific researcher, professor, and senior administrator at leading academic institutions and hospitals, bringing scientific leadership and expertise in oncology, genetics, and pediatric research.